Last updated on November 2015

A Pilot Study of TRV130 for the Treatment of Fracture Pain


Brief description of study

The primary objective is to evaluate the analgesic efficacy of TRV130 for moderate to severe acute pain in patients presenting to the emergency department (ED) with a suspected/known, unilateral, closed long bone fracture.

Detailed Study Description

This study is designed to evaluate the analgesic efficacy of TRV130 for the treatment of moderate to severe acute pain associated with a long bone fracture in patients presenting to the ED. The safety and tolerability of TRV130 will also be evaluated in this open-label pilot study.

Clinical Study Identifier: NCT02520297

Contact Investigators or Research Sites near you

Start Over

Trevena

Trevena, Inc.
Indianapolis, IN United States
  Connect »